News

This grant follows recent key milestones for Eligo, including the publication of its microbiome base-editing platform in ...
Enrolled first patients in first 4D-150 Phase 3 clinical trial (4FRONT-1) in wet AMD, with over 50 clinical trial sites open to dateInitiation of second 4D-150 Phase 3 clinical trial (4FRONT-2) expect ...
Enrolled first patients in first 4D-150 Phase 3 clinical trial (4FRONT-1) in wet AMD, with over 50 clinical trial sites open to date Initiation of second 4D-150 Phase 3 clinical trial (4FRONT-2) ...
Through strategic acquisitions made by New York–based investment firm Altaris, Minaris Regenerative Medicine and the U.S. and ...
Centric Therapies Shape the Future of Gene Therapy in OphthalmologyDublin, May 07, 2025 (GLOBE NEWSWIRE) -- The "Gene Therapy in Ophthalmology Market - A Global and Regional Analysis: Focus on ...
D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment ...
D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment ...
Miami is a town of alligators and hurricanes and bad boob jobs — in real life and on a new Netflix medical drama called “Pulse.” The fictional show follows third-year medical resident Dr ...
The research, to be published April 23 in the journal Science Translational Medicine, tracked the biodistribution ... by sucking up sugars from its tick vector. Upon bacterial cell death - by ...
Control was restored only after reintroducing mass drug administration, robust vector control, and community mobilisation. This highlights the danger of prematurely scaling back efforts and the need ...
Cleaning out your medicine cabinet is essential during seasonal transitions. NBC News medical contributor Dr. Natalie Azar stops by TODAY to share three simple steps you can take to get started ...